Cellectar Biosciences Inc (CLRB)

NASDAQ

$2.52

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of drugs for the treatment of cancer. The company is headquartered in Florham Park, New Jersey.

Website: https://www.cellectar.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Strong Buy

Target: $11.50 (+356.35%)

Market Cap

$15M

Price Chart

Adjust inflation

Log

Valuation

Market Cap$15M

P/S348.47

P/B1.51

Profitability

EBITDA-$23M

EPS-$9.95

Growth & Risk

EPS 5Y CAGR-28.93%

FCF 5Y CAGR+12.48%

Sharpe Ratio-0.47